Oscillococcinum® for upper respiratory tract infections and exacerbations in COPD: an observational, prospective study (OXITUNIS)
Background: Upper respiratory tract infections (URTIs) are a major cause of exacerbations in patients with chronic obstructive pulmonary disease (COPD). We assessed the effectiveness of Oscillococcinum® in the protection from URTIs in patients with COPD who had been vaccinated against influenza infe...
Saved in:
Main Authors: | Hichem Aouina (Author), Anis Bamri (Author), Aurélien Vesin (Author), Karine Danno (Author), Eléonore Aubry (Author), Cécile Faure (Author), Naoual Boujedaini (Author) |
---|---|
Format: | Book |
Published: |
BioExcel Publishing Ltd,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oscillococcinum for influenza treatment
by: Luigi Alberto Marrari, et al.
Published: (2012) -
The preventive effect on respiratory tract infections of Oscillococcinum®. A cost-effectiveness analysis
by: Colombo GL, et al.
Published: (2018) -
Stress Cardiomyopathy in the Setting of COPD Exacerbation
by: Kevin Landefeld, et al.
Published: (2015) -
Exposure to Air Pollution Exacerbates Inflammation in Rats with Preexisting COPD
by: Jing Wang, et al.
Published: (2020) -
Anti-oxidant Effect of High Dilutions of , and in Microglial Cells
by: Anne Paumier, et al.
Published: (2022)